4 S U P P L E M E N T T O O U T PAT I E N T S U R G E R Y M A G A Z I N E J a n u a r y 2 0 1 5
Product & Services
SHOWCASE
choose surgical sTreTcher chairs for BesT efficiency
TransMotion Medical's TMM5 Surgical Stretcher-Chair streamlines patient
movement through the surgical care cycle. With MOTORIZED POSITIONING,
the TMM5 functions as a pre-op chair, a transport stretcher, an outpatient
surgical table, and a recovery recliner—-all in ONE!
It allows for superior surgeon access with industry-leading leg clearance
and the articulating headpiece allows for exceptional patient positioning.
Motorized Stretcher-Chairs Help Eliminate Patient Transfers.
This delivers:
• Reduced Staff Injury and Patient Fall Risk • Space Savings
• Operational Cost Savings • Improves Patient Experience
• Improves Throughput - LEAN
It's the number one Stretcher-Chair of choice that will ensure your safety
and efficiency while enhancing patient comfort.
Perfect for outpatient surgeries including: ophthalmology, plastic, oral and
hand surgery, ENT, emergency, and more! The patient goes from pre-op, to
surgery, to post-op…all on a single surface!
For more information call
(866) 860-8447
,
visit
www.TransMotionMedical.com
or
use the reader service card on p. 6
.
look for us at the aorn show, Booth #4132 in Denver
.
This MiToMycin kiT is fDa-approveD for eye surgery
Mobius Therapeutics, LLC manufactures and markets Mitosol®, (mitomycin for
solution) 0.2 mg/vial, Kit for Ophthalmic Use, the only FDA-approved oph-
thalmic formulation of mitomycin. Mitosol® permits room temperature storage
without light shielding and features an extended shelf life. Assured sterility,
potency, and dosing along with closed transfer and qualified disposal reinvents
mitomycin for ophthalmology. Mobius has received notice from the Center for
Medicare Services (CMS) of an Outpatient Prospective Payment System (OPPS)
Payment Indicator "K2" for the code J7315 Mitosol® (mitomycin for solution) Kit
for Ophthalmic Use. This payment indicator allows payment for entities billing
under OPPS, including Ambulatory Surgical Centers (ASCs) and hospitals.
This code cannot be used to reimburse compounded mitomycin.
For more information call
(877) 393-6486
, visit
www.MobiusTherapeutics.com
or
use the reader service card on p. 6
.
Queaseease inhaler for ponv
The natural, hospital proven, drug-free and CRNA-designed
aromatic inhaler for nausea relief is now available in two
convenient options. The single patient disposable Quick
Pack is essential for fast rescue relief at the onset of PONV
and will last for two days. The innovative twist-to-open
aromatic inhaler is fantastic for recurring nausea and lasts
for six months. QueaseEASE works immediately as a rescue
for patients experiencing nausea following surgery in the
PACU, the car ride home, or even during recovery.
QueaseEASE reduces PACU time, cuts overhead and nursing
time per patient! Patients LOVE QueaseEASE and can
administer it themselves, giving an important sense of
control. QueaseEASE is also effective for post-op,
chemotherapy or even morning sickness.
For more information call
(888) 393-7330
,
email
osM@soothing-scents.com
or
use our reader service card on p. 6
.